fashion -WSS

fashion

author：explore 2025-10-01 04:10:25 - browse：6

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Zapping the brain for stroke rehab: Pivotal clinical trial begins

Wikipedia

WSS

Smaller biotechs seek to piggyback on weight loss drug boom

CDC launches VaccineFinder tool to locate Covid

CDC launches VaccineFinder tool to locate Covid

Roivant's CEO is a star, but biotech's black hole persists

FTX founder Sam Bankman

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

focus

fashion

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Walensky prepares to leave CDC — and Congress — behind

Hospitals use virtual reality to design more inclusive rooms for kids

Dobbs anniversary: the lost opportunity of abortion as health care

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Virginia high school admissions case could be legal follow

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

In Memoriam: Notable people who died in 2023

Discs beat pads, tampons for heavy menstrual flow, new study shows

explore

Is there really a nursing shortage in the U.S.?

Hospitals use virtual reality to design more inclusive rooms for kids

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Study on Amgen’s bispecific immunotherapy produces positive data

Discs beat pads, tampons for heavy menstrual flow, new study shows

Roche drug slashes death risk in early

hotspot

focus

Wikipedia

entertainment